➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Drug Price Trends for CIMETIDINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for CIMETIDINE

Average Pharmacy Cost for CIMETIDINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CIMETIDINE 300 MG TABLET 00093-8192-01 0.33995 EACH 2020-07-22
CIMETIDINE 800 MG TABLET 00378-0541-01 0.84339 EACH 2020-07-22
CIMETIDINE 300 MG TABLET 00093-8192-05 0.33995 EACH 2020-07-22
CIMETIDINE 400 MG TABLET 00093-8204-01 0.57110 EACH 2020-07-22
CIMETIDINE 200 MG TABLET 00378-0053-01 0.31499 EACH 2020-07-22
CIMETIDINE 300 MG TABLET 00378-0317-01 0.33995 EACH 2020-07-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CIMETIDINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TAGAMET 300MG TAB AvKare, Inc. 42291-0217-90 90 33.25 0.36944 EACH 2018-01-01 - 2022-12-31 FSS
TAGAMET 300MG TAB AvKare, Inc. 42291-0217-90 90 32.21 0.35789 EACH 2018-05-18 - 2022-12-31 FSS
CIMETIDINE 400MG TAB AvKare, Inc. 42291-0218-01 100 43.99 0.43990 EACH 2018-01-01 - 2022-12-31 FSS
CIMETIDINE HCL 300MG/5ML LIQUID,ORAL Golden State Medical Supply, Inc. 50383-0050-08 237ML 18.15 0.07658 ML 2018-01-01 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.